Rakotoarisaona Mendrika Fifaliana, Razafimaharo Tsiory Iarintsoa, Sendrasoa Fandresena Arilala, Andrianarison Malalaniaina, Razanakoto Naina Harinjara, Ratovonjanahary Volatantely Tobiniaina, Raharolahy Onivola, Ranaivo Irina Mamisoa, Ramarozatovo Lala Soavina, Rapelanoro Rabenja Fahafahantsoa
Department of Dermatology, University Hospital of Analakely, Antananarivo, Madagascar.
Department of Dermatology, University of Befelatanana, Antananarivo, Madagascar.
Infect Drug Resist. 2024 Apr 15;17:1507-1513. doi: 10.2147/IDR.S458888. eCollection 2024.
Leprosy and tuberculosis are two of the oldest and most common mycobacterial infections, caused by and for leprosy and for tuberculosis. Dual infections have been known since ancient times; however, cases remain rarely reported in the literature, even in countries where both diseases are endemic, such as Madagascar.
We report a case series of simultaneous occurrence of leprosy and tuberculosis.
In this retrospective study, we reviewed the medical records of patients with leprosy registered at the Department of Dermatology, University Hospital Befelatanana, Antananarivo, Madagascar, between January 2012 and June 2021. Patients with leprosy and diagnosed as coinfected by tuberculosis were included in the study.
Of the 120 leprosy cases observed during the study period, coinfection with leprosy and tuberculosis was found in five patients. The mean age was 43.4 (SD 13.2) ranging, 21-59 years. Male gender was predominant (4/5). Four patients presented with lepromatous leprosy, and one with borderline lepromatous leprosy. Three patients experienced leprosy reaction. Four cases of pulmonary tuberculosis and one case of multifocal tuberculosis were observed. The diagnosis of leprosy preceded tuberculosis in four cases, and a coinfection diagnosis was made simultaneously in one case. The average time to develop tuberculosis was 38.8 (SD 10.2) months. HIV infection, malnutrition, alcohol consumption, and long-term corticosteroid therapy were the immunosuppressive factors reported in our patients. Three patients received concomitant multidrug therapy for leprosy and tuberculosis.
Dermatologists should be aware of the importance of screening patients affected by leprosy for latent or active tuberculosis to prevent morbidity and mortality due to coinfection and to reduce the risk of acquired resistance to rifampicin, which is the greatest risk of this association.
麻风病和结核病是两种最古老且最常见的分枝杆菌感染,分别由麻风分枝杆菌和结核分枝杆菌引起。双重感染自古就为人所知;然而,即便在两种疾病都为地方病的国家,如马达加斯加,文献中报道的病例仍然很少。
我们报告一组麻风病和结核病同时发生的病例系列。
在这项回顾性研究中,我们查阅了2012年1月至2021年6月期间在马达加斯加塔那那利佛贝费拉塔纳纳大学医院皮肤科登记的麻风病患者的病历。纳入研究的患者为患有麻风病且被诊断为合并结核病感染的患者。
在研究期间观察的120例麻风病病例中,发现5例患者同时感染了麻风病和结核病。平均年龄为43.4岁(标准差13.2),年龄范围为21至59岁。男性占主导(4/5)。4例患者表现为瘤型麻风,1例为界线类偏瘤型麻风。3例患者发生了麻风反应。观察到4例肺结核和1例多灶性结核。4例患者先诊断为麻风病,后诊断为结核病,1例同时诊断为双重感染。发生结核病的平均时间为38.8个月(标准差10.2)。我们的患者中报告的免疫抑制因素包括艾滋病毒感染、营养不良、饮酒和长期使用皮质类固醇治疗。3例患者同时接受了麻风病和结核病的联合多药治疗。
皮肤科医生应意识到对麻风病患者进行潜伏性或活动性结核病筛查的重要性,以预防因双重感染导致的发病和死亡,并降低获得利福平耐药性的风险,这是这种关联的最大风险。